Aytu BioPharma Inc (AYTU)
3.09
+0.08
(+2.66%)
USD |
NASDAQ |
May 06, 16:00
3.06
-0.03
(-0.97%)
Pre-Market: 20:00
Aytu BioPharma Price: 3.09 for May 6, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
May 06, 2024 | 3.09 | 3.17 | 3.04 | 3.09 | 43175.00 |
May 03, 2024 | 2.96 | 3.04 | 2.92 | 3.01 | 21150.00 |
May 02, 2024 | 2.95 | 3.01 | 2.95 | 3.01 | 7349.00 |
May 01, 2024 | 2.86 | 2.95 | 2.85 | 2.893 | 7940.00 |
Apr 30, 2024 | 2.82 | 2.891 | 2.81 | 2.81 | 2653.00 |
Apr 29, 2024 | 2.91 | 2.927 | 2.805 | 2.81 | 4018.00 |
Apr 26, 2024 | 2.90 | 2.92 | 2.88 | 2.904 | 6144.00 |
Apr 25, 2024 | 2.79 | 2.865 | 2.711 | 2.84 | 8003.00 |
Apr 24, 2024 | 2.80 | 2.80 | 2.63 | 2.80 | 13960.00 |
Apr 23, 2024 | 2.85 | 2.85 | 2.715 | 2.715 | 9066.00 |
Apr 22, 2024 | 2.75 | 2.883 | 2.75 | 2.810 | 6647.00 |
Apr 19, 2024 | 2.80 | 2.833 | 2.74 | 2.79 | 6921.00 |
Apr 18, 2024 | 2.87 | 2.932 | 2.79 | 2.79 | 3294.00 |
Apr 17, 2024 | 2.94 | 2.94 | 2.760 | 2.873 | 4312.00 |
Apr 16, 2024 | 2.68 | 2.92 | 2.68 | 2.86 | 7382.00 |
Apr 15, 2024 | 2.85 | 2.86 | 2.65 | 2.68 | 55660.00 |
Apr 12, 2024 | 3.11 | 3.120 | 2.837 | 2.890 | 26498.00 |
Apr 11, 2024 | 3.22 | 3.22 | 3.082 | 3.12 | 26603.00 |
Apr 10, 2024 | 3.27 | 3.38 | 3.15 | 3.217 | 13404.00 |
Apr 09, 2024 | 3.27 | 3.38 | 3.27 | 3.36 | 13225.00 |
Apr 08, 2024 | 3.10 | 3.35 | 3.10 | 3.30 | 40063.00 |
Apr 05, 2024 | 3.16 | 3.22 | 3.092 | 3.22 | 15837.00 |
Apr 04, 2024 | 3.10 | 3.20 | 2.982 | 3.20 | 21840.00 |
Apr 03, 2024 | 3.04 | 3.13 | 3.04 | 3.13 | 12051.00 |
Apr 02, 2024 | 2.98 | 3.04 | 2.98 | 3.03 | 10254.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.49
Minimum
Jun 28 2023
464.00
Maximum
May 08 2019
106.02
Average
49.80
Median
Oct 29 2021
Price Benchmarks
Regen BioPharma Inc | 0.6100 |
Clearday Inc | 0.675 |
Bioxytran Inc | 0.102 |
Shuttle Pharmaceuticals Holdings Inc | 0.439 |
CEL-SCI Corp | 1.72 |
Price Related Metrics
PS Ratio | 0.1474 |
Price to Book Value | 0.5237 |
Price to Free Cash Flow | 2.374 |
Earnings Yield | -130.7% |
Market Cap | 17.20M |